Just returned from my ~43rd American Academy of Ophthalmology meeting in Chicago. where I saw many colleagues and friends while getting up to date on ophthalmology from anterior to posterior. i was pleased to see presentations on clinical data from many of our clients, and to discuss many projects for novel therapeutics
Dr. Gary Novack is a board-certified clinical pharmacologist and President of PharmaLogic Development with more than 40 years of experience in ophthalmic drug development, clinical research, and FDA regulatory strategy.
He has consulted for over 100 pharmaceutical and medical device companies and authored more than 400 scientific publications.